Skip to main navigation Skip to search Skip to main content

The ALS-FTD-Q: A new screening tool for behavioral disturbances in ALS

  • J. Raaphorst
  • , E. Beeldman
  • , B. Schmand
  • , J. Berkhout
  • , W.H.J.P. Linssen
  • , L.H. Van den Berg
  • , Y.A.L. Pijnenburg
  • , H.F. Grupstra
  • , J.G. Weikamp
  • , H.J. Schelhaas
  • , J.M. Papma
  • , J.C. van Swieten
  • , M. de Visser
  • , R.J. de Haan

Research output: Contribution to Journal › Article › Academic › peer-review

805 Downloads (Pure)

Abstract

Objective: The assessment of behavioral disturbances in amyotrophic lateral sclerosis (ALS) is important because of the overlap with the behavioral variant of frontotemporal dementia (ALS-bvFTD). Motor symptoms and dysarthria are not taken into account in currently used behavioral questionnaires. We examined the clinimetric properties of a new behavioral questionnaire for patients with ALS (Amyotrophic Lateral Sclerosis-Frontotemporal Dementia-Questionnaire [ALS-FTD-Q]). Methods: In addition to other clinimetric properties, we examined reliability, clinical validity, and construct validity of the ALS-FTD-Q, using data from patients with ALS (n = 103), ALS-bvFTD (n = 10), bvFTD (n = 25), muscle disease control subjects (n = 39), and control subjects (n = 31). Construct validity of the ALS-FTD-Q was assessed using the Frontal Systems Behavior scale (FrSBe), Frontal Behavioral Inventory (FBI), Hospital Anxiety and Depression Scale, ALS Functional Rating Scale Revised, Frontal Assessment Battery, Mini-Mental State Examination, and a fluency index. In addition, the point prevalence of behavioral disturbances according to the ALSFTD- Q was compared with those obtained with the FrSBe and FBI. Results: The internal consistency of the ALS-FTD-Q was good (Cronbach α = 0.92). The ALSFTD- Q showed construct validity because it correlated highly with other behavioral measures (r = 0.80 and 0.79), moderately with measures of frontal functions and global cognitive functioning (r = 0.37; r = 0.32), and poorly with anxiety/depression and motor impairment (r = 0.18 for both). The ALS-FTD-Q discriminated between patients with ALS-bvFTD, patients with ALS, and control subjects. The point prevalence of behavioral disturbances in patients with ALS measured with the ALS-FTD-Q was lower than that for the FrSBe and FBI. Conclusion: The ALS-FTD-Q is a feasible and clinimetrically validated instrument for the screening of behavioral disturbances in ALS. © 2012 by AAN Enterprises, Inc.
Original languageEnglish
Pages (from-to)1377-1383
JournalNeurology
Volume79
Issue number13
DOIs
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 16 - Peace, Justice and Strong Institutions
    SDG 16 Peace, Justice and Strong Institutions

Fingerprint

Dive into the research topics of 'The ALS-FTD-Q: A new screening tool for behavioral disturbances in ALS'. Together they form a unique fingerprint.

Cite this